Outcome Measures of Modified Constraint Induced Movement Therapy Versus Dual Task Training on Upper Extremity and Cognitive Functions in Patients With Hemiparesis

Hemiparesis Clinical Trial

Official title:

Outcome Measures of Modified Constraint Induced Movement Therapy Versus Dual Task Training on Upper Extremity and Cognitive Functions in Patients With Hemiparesis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06457022
• Other study ID #: P.T.REC/012/005007
• Status: Completed
• Phase: N/A
• Start date: December 5, 2023
• Est. completion date: May 5, 2024

Study information

• Verified date: June 2024
• Source: AlRyada University for Science & Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

All stroke patients were assessed via isokinetic dynamometer, Montreal cognitive assessment scale (MOCA) and Fugl Myer Upper extremity (FMUE) before and after the treatment program.

Description:

The patients were classified randomly into three equal groups, Study group A (GA) receiving modified constraint induced movement therapy in addition to conventional physical therapy program, Study group B (GB) receiving dual task training in addition to conventional physical therapy program and control group C (GC) receiving only conventional physiotherapy program.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: May 5, 2024
• Est. primary completion date: March 5, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 55 Years to 65 Years

Eligibility

Inclusion Criteria:

• Patients with age range between 55 and 65 years old.

• The patients were from both genders (males &females).

• Patients were of duration of illness between 6 and 12 months.

• The patients were scoring 1 &1+ on modified Ashworth scale (mild spasticity).

• The patients were of good ability to see and hear.

• Consent form was obtained from all participants to approve the study and follow the commands.

• All patients were scoring more than 26 on MMSE. All patients were medically stable.

Exclusion Criteria:

• patients with moderate and sever spasticity.

• patients with cognitive disorder due to other cause rather than spasticity.

• patients with unstable medical conditions.

• patients with previous or recurrent stroke.

• patients with respiratory problems.

• patients with shoulder dislocation or subluxation or frozen shoulder.

• patients with uncontrolled hypertension, diabetes mellitus, unstable angina or heart failure.

Related Conditions & MeSH terms

• Hemiparesis
• Paresis

Intervention

Other:
• Modified Constraint Induced Movement therapy
patient wears a restraint instrument in his unaffected hand, then applying massed practice to his affected upper extremity. The patient wears padded glove in his unaffected upper extremity for restraining the patient from using his unaffected upper extremity for about 3 hours per day including the treatment session and the home program. So, by this way the patient is reinforced to use his affected upper extremity during this period of time to achieve his activities of daily living. Finally, the total time, the patient spends it during the day wearing the glove should be recorded each day.
• Dual task training in the form of cognitive - motor task
Verbal fluency: Ask the hemiparetic patient to title many words of specific type as fruits, vegetable or animals. Mental tracking: as the hemiparetic patient to subtract serial 3 between number 90 and 100.
• Conventional physiotherapy rehabilitation program
Ultrasound on shoulder. Graduated active exercises for shoulder. Prolonged stretching for spastic muscles

Locations

Country	Name	City	State
Egypt	Al Ryada University for Science and Technology	Sadat	Menoufia

Sponsors (1)

Lead Sponsor	Collaborator
Ahmed Alshimy

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Biodex isokinetic dynamometer	Used to assess muscle strength and function	6 weeks
Primary	Montreal cognitive assessment	a quick test that is used to examine mild cognitive impairment and early dementia.	6 weeks
Primary	Fugl Myer upper extremity	a scale used to measure the functional impairment of stroke	6 weeks